Oral Clindamycin Causing Acute Cholestatic Hepatitis Without Ductopenia: a Brief Review of Idiosyncratic Drug-induced Liver Injury and a Case Report
Overview
Affiliations
Clindamycin is a lincosamide antibiotic active against most of the anaerobes, protozoans, and Gram-positive bacteria, including community-acquired methicillin-resistant Staphylococcus aureus. Its use has increased greatly in the recent past due to wide spectrum of activity and good bioavailability in oral form. Close to 20% of the patients taking clindamycin experience diarrhea as the most common side effect. Hepatotoxicity is a rare side effect. Systemic clindamycin therapy has been linked to two forms of hepatotoxicity: transient serum aminotransferase elevation and an acute idiosyncratic liver injury that occurs 1-3 weeks after starting therapy. This article is a case report of oral clindamycin induced acute symptomatic cholestatic hepatitis and a brief review of the topic.
var. Flower Essential Oil Reduces MRSA Pathogenicity by Inhibiting Virulence Gene Expression.
Kim J, Park B, Kim Y, Yoon J, Choi N, Kim K Molecules. 2025; 30(3).
PMID: 39942657 PMC: 11820971. DOI: 10.3390/molecules30030553.
Clindamycin: A Comprehensive Status Report with Emphasis on Use in Dermatology.
Del Rosso J, Armillei M, Lomakin I, Grada A, Bunick C J Clin Aesthet Dermatol. 2024; 17(8):29-40.
PMID: 39148960 PMC: 11324192.
Blood coagulation factors and platelet response to drug-induced hepatitis and hepatosis in rats.
Korolova D, Gryshchenko V, Chernyshenko T, Platonov O, Hornytska O, Chernyshenko V Animal Model Exp Med. 2022; 6(1):66-73.
PMID: 36574273 PMC: 9986226. DOI: 10.1002/ame2.12301.
Okudo J, Anusim N Case Reports Hepatol. 2016; 2016:2724738.
PMID: 27462474 PMC: 4947643. DOI: 10.1155/2016/2724738.
Rapid assessment of health literacy on admission to the hospital.
Ferguson R J Community Hosp Intern Med Perspect. 2015; 5(5):29131.
PMID: 26486120 PMC: 4612485. DOI: 10.3402/jchimp.v5.29131.